Cargando…
2‐Deoxy‐d‐glucose induces deglycosylation of proinflammatory cytokine receptors and strongly reduces immunological responses in mouse models of inflammation
Anti‐proinflammatory cytokine therapies against interleukin (IL)‐6, tumor necrosis factor (TNF)‐α, and IL‐1 are major advancements in treating inflammatory diseases, especially rheumatoid arthritis. Such therapies are mainly performed by injection of antibodies against cytokines or cytokine receptor...
Autores principales: | Uehara, Ikuno, Kajita, Mitsuko, Tanimura, Atsuko, Hida, Shigeaki, Onda, Munehiko, Naito, Zenya, Taki, Shinsuke, Tanaka, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873284/ https://www.ncbi.nlm.nih.gov/pubmed/35212163 http://dx.doi.org/10.1002/prp2.940 |
Ejemplares similares
-
Comparison of Epirubicin-Iodized Oil Suspension and Emulsion for Transcatheter Arterial Chemoembolization in VX2 Tumor
por: Ueda, Tatsuo, et al.
Publicado: (2012) -
The N-glycan Glycoprotein Deglycosylation Complex (Gpd) from Capnocytophaga canimorsus Deglycosylates Human IgG
por: Renzi, Francesco, et al.
Publicado: (2011) -
Correction: The N-glycan Glycoprotein Deglycosylation Complex (Gpd) from Capnocytophaga canimorsus Deglycosylates Human IgG
por: Renzi, Francesco, et al.
Publicado: (2015) -
Too sweet: cheminformatics for deglycosylation in natural products
por: Schaub, Jonas, et al.
Publicado: (2020) -
Liver Involvement in Congenital Disorders of Glycosylation and Deglycosylation
por: Lipiński, Patryk, et al.
Publicado: (2021)